PIM-1 Kinase: A Potential Biomarker of Triple-Negative Breast Cancer

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s212752
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

CREB3L1 as a Potential Biomarker Predicting Response of Triple Negative Breast Cancer to Doxorubicin-Based Chemotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Triple-Negative Breast Cancer

2018English

A Review of Triple-Negative Breast Cancer

Cancer Control
MedicineOncologyHematology
2010English

Silencing of Casein Kinase 1 Delta Reduces Migration and Metastasis of Triple Negative Breast Cancer Cells

Oncotarget
Oncology
2018English

ICAM-1 as a Molecular Target for Triple Negative Breast Cancer

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2014English

Phase II and Biomarker Study of Cabozantinib in Metastatic Triple‐Negative Breast Cancer Patients

Oncologist
Cancer ResearchMedicineOncology
2017English

Triple Negative Breast Cancer: Breast Cancer Research in Evolution

Breast Disease
MedicineCancer ResearchOncology
2011English

Estrogen Receptor-Beta Is a Potential Target for Triple Negative Breast Cancer Treatment

Oncotarget
Oncology
2018English

Triple Negative Breast Cancer: Heterogenous Disease

REVIEWS IN ONCOLOGY
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy